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Endocannabinoids (eCBs) are involved in the hippocampal mechanisms of spatial learning and memory in rats. Although eCBs exert 
many of their actions on spatial learning and memory via CB1 receptors, the putative cannabinoid receptor GPR55 (expressed in 
the hippocampus, cortex, forebrain, cerebellum and striatum) seems to be also involved. To investigate the potential role of GPR55 
in spatial learning and memory, Wistar rats received bilateral infusions of lysophosphatidylinositol (LPI, GPR55‑agonist) into the 
hippocampus 5‑minutes before training‑phase in the Barnes‑maze (BM). This manipulation increased the use of serial navigation 
while preventing the learning of spatial navigation strategy and decreasing the use of random activity to find the escape‑tunnel in the 
BM. In contrast, CID16020046 (GPR55‑antagonist) increased the use of random activity at the expense of spatial and serial navigation 
strategies. Finally, CID16020046 significantly reduced the time spent in the target zone during a retention test. Our results suggest: 
(i) a potential role of GPR55 in developing navigation strategies; (ii) a prospective function for LPI acting in hippocampal CA1 (probably 
via GPR55) to perform a serial navigation strategy; and (iii) a potential role of GPR55 in the mechanisms involved in spatial memory 
(object placement memory).
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INTRODUCTION
Apart from the well‑characterized cannabinoid type 
1 and type 2 receptors, there is evidence that endocan‑
nabinoids (eCBs) exert their actions via putative canna‑
binoid G‑protein receptor 55 (GPR55) (Lauckner et al. 
2008, Marichal‑Cancino et al. 2013, 2016, 2017, Yang et 
al. 2016). Cannabinoids affect behaviours related with 
hippocampal activity via CB1 receptors (e.g., long‑term 
potentiation; Basavarajappa et al., 2014), but few stud‑
ies have investigated the physiological role of hippo‑
campal GPR55 (Hurst et al. 2017, Kramar et al. 2017, 
Rojo et al. 2012, Sylantiev et al. 2013).  There is GPR55 
mRNA in the hippocampus and other brain areas (Ry‑
berg et al. 2007, Wu et al. 2013). According with Kramar 
et al. (2017), injections of palmitoylethanolamide into 
ventral hippocampus affected spatial memory proba‑
bly via GPR55. Hurst et al. (2017) recently reported that 
hippocampal GPR55 stimulation with lysophosphatidy‑
linositol improved synaptic plasticity. 
In contrast, systemic augments of anandamide 
(which activates both CB1 and GPR55) by fatty acid 
amide hydrolase (FAAH) inhibitors (enzyme that par‑
ticipates importantly in endocannabinoids clearance) 
impaired LTP, learning and memory. In addition, in‑
fusions of anandamide into the hippocampal area 
CA1 modified spatial navigation (Rueda‑Orozco et 
al. 2008). It is important to note (Table I) that sever‑
al cannabinoids exert actions on both CB1 and GPR55 
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receptors (Henstridge et al. 2010). At this respect, we 
reported that stimulation of GPR55 in dorsal striatum 
seemed to improve procedural memory, whereas CB1 
stimulation seemed to impair it (Marichal‑Cancino et 
al. 2016). 
As few data are available for the role of hippocampal 
GPR55, this study investigated the effects of its phar‑
macological manipulation on spatial navigation strate‑
gies to solve the Barnes‑maze (BM) in Wistar rats. 
METHODS
Subjects
Wistar male rats weighing 250–300 g at the begin‑
ning of the experiments were used (N=32). Animals 
were housed individually under controlled conditions, 
temperature 21±1°C, 52% humidity, a reverse 12‑h 
light/dark cycle; lights on at 20:00 h with ad libitum ac‑
cess to water and food. Experiments started at 08:00 h. 
Every protocol adhered to the provisions of the Offi‑
cial Mexican Regulation on “Technical specifications 
for the production, care and use of laboratory animals” 
(NOM‑062‑ZOO‑1999). The Research and Ethics Com‑
mittee of the School of Medicine (UNAM) accepted this 
study. This study was constructed in accordance with 
the Guidelines of the U.S. Public Health Service and NIH 
regarding the care and use of animals for experimen‑
tation and with the ARRIVE guidelines (McGrat et al. 
2010).
Experimental groups
Animals were randomly divided in two main sets 
(set 1 n=8; set 2 n=24). In set 1 (n=8) rats received 
no manipulation or surgery before training (intact 
group). After surgery recovery (see below), set 2 was 
divided in three groups (n=8 each group), which re‑
ceived CA1 hippocampal injections (0.5μl) of: (i) DMSO 
100% (vehicle group); (ii) 10 nM of LPI; or (iii) 10 nM 
of CID16020046.
Surgery and cannulae placement verification
Rats were implanted bilaterally in the hippocam‑
pal area CA1 under an anaesthesia cocktail (ketamine 
66 mg/kg plus xylazine 0.26 mg/kg plus aceproma‑
zine 1.3 mg/kg). A couple of guide cannulae (23‑gauge, 
0.6 mm of outer diameter) were affixed to the skull 
with dental cement, according to Paxinos and Watson 
(2007) coordinates (P=0.4, L=2.5, V=2.2). Animals were 
allowed to recover from surgery for ten days. 
Once the experiments ended, rats were sacrificed 
with an overdose of sodium pentobarbital and tran‑
scardially perfused with 200 ml of PBS and 200 ml of 4% 
of paraformaldehyde to prepare the brains for histo‑
logical analysis with cresyl violet staining to verify the 
correct placement of the injector (Fig. 1), as previously 
described (Rueda‑Orozco et al. 2008). 
Intra‑hippocampal administrations of DMSO, LPI 
and CID16020046
Animals from set 1 and set 2 were kindly handled 2 h 
during 2 days before any experimental manipulation 
to diminish stress as previously reported (Soria‑Gó‑
mez et al. 2007). 15 minutes before each training day 
(i.e., session 1–4; see Fig. 2) in the Barnes‑maze (BZ) 
animals from set 1 were handled for 5 min and allowed 
to stay at home cages during other 10 min. Animals 
from set 2 were hippocampal infused with DMSO, LPI 
Table  I. Affinity of Noladin‑ether, AM251 and CID16020046 for CB1 and 
GPR55.
Compound CB1 GPR55
Lysophosphatidylinositol <4.5
 1
pEC50
5.9 1
pEC50
AM251 7.7
 2
pIC50
6.2 3
pEC50
CID16020046 Not detected 4 >6.2
 4
pIC50
Δ9‑tetrahydrocannabinol 8.1
 5
pEC50
8.2 5
pEC50
Data taken from: 1 Kapur et al. 2009, 2 Brigthon et al. 2009, 3 Henstridge et al. 2010, 
4 Kargl et al. 2013, 5 Ryberg et al. 2007.
Fig. 1. Photomicrographic and schematic representation (taken from 
Swanson, 2004) of the injection sites in the hippocampus.
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or CID16020046 0.5 μl in 5 min each side (final volume 
1μl). Then, animals stayed at cage homes for 10 min be‑
fore training to allowed distribution of treatments as 
previously reported (Marichal‑Cancino et al. 2016). 
Barnes maze and strategy criteria
Our BM was an adaptation from the original appa‑
ratus published by Barnes (1979) consisting of a cir‑
cular wooden disk (150 cm of diameter; 2.0 cm thick, 
90 cm height). At 4.5 cm from the edge, forty holes 
(7 cm diameter) were equidistantly located through‑
out the disk (Fig. 2). A black wooden box was used as 
an escape tunnel (10×10×30 cm) randomly placed be‑
neath one hole which was different for each rat. From 
a speaker affixed to the room’s ceiling and located 1 m 
over the center of the maze, a white noise (90 dB) was 
delivered. Although the escape tunnel was always at 
the same spatial position, the BM was rotated for each 
trial to prevent use of clues on the apparatus surface. 
The BM was thoroughly cleaned with a 5% chlorine 
solution after every trial. Three types of navigation 
were evaluated in each trial: 
Serial navigation strategy
To be considered as a serial strategy, once rats vis‑
ited a hole, they had to explore adjacent holes sequen‑
tially and follow one direction until finding the hole 
with the escape tunnel (Fig. 2A). 
Spatial navigation strategy
In this case, rats visit the hole with the escape tun‑
nel directly or at most two adjacent holes to the left or 
to the right (target zone) with no visits to holes outside 
of this zone until they escape (Fig. 2B). 
Random navigation escape
Any procedure used to escape which did not fit the 
criteria for serial or spatial strategy was automatically 
considered as a random escape (Fig. 2C).
Latency to escape and errors
In addition to the navigation strategies, latency to 
escape and errors were measured. An error was con‑
Fig.  2. Schematic example of navigation strategies to solve the Barnes‑maze and protocol time line. In serial navigation, rats visit subsequent holes 
following one direction until they find the escape tunnel (A), in spatial navigation, rats go directly to the escape tunnel with no visits outside of the target 
zone (B), all navigation different to serial or spatial was considered as random (C). Session days are shown (D). 
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sidered to any visit to holes different from the escape 
tunnel. A daily session consisted of 4 trials; each trial 
ended, when the rat entered the escape tunnel or once 
4 min elapsed. If after 4 min, the rat failed to enter 
the escape tunnel, they were gently guided to it, and 
the trial was considered as an omission, as previously 
described (Rueda‑Orozco et al. 2008). According with 
our criteria, if an animal did not learn to locate the 
escape tunnel after 2 trials, it was discarded. However, 
none of the rats met this criterion. A learning curve 
was obtained at the end of the training phase, depict‑
ing the reduction of the time required to find the es‑
cape tunnel.
Behavioural training and treatment infusions
Ten days after the surgery, rats were trained to 
solve the BM for 4 consecutive days (S1–S4). Every 
training session day was video recorded. Before the 
beginning of the first trial, rats were placed in the 
escape tunnel for 1 min to make them familiar with 
it, as we have previously described (Rueda‑Orozco et 
al. 2008). Upon completion of this time, animals were 
placed in a removable cylindrical chamber (15 cm 
diameter) situated in the centre of the BM, while 
a white noise (90 dB) was delivered from a speaker lo‑
cated in the ceiling of the room (1.5 m above the BM). 
Once rats spent 10 seconds in this condition they were 
let free and allowed to explore until they escaped or 
4 min elapsed. When rats entered the escape tunnel, 
the white noise went off. Between each trial the BM 
was thoroughly cleaned with a 5% chlorine solution 
and rotated to prevent rats from using non‑con‑
trolled BM clues, albeit the escape tunnel remained 
in the same spatial place per rat. The location of the 
escape tunnel was randomly assigned per rat. Once 
the location of the escape tunnel was determined, it 
remained in the same spatial location for the entire 
study. Rats were randomly assigned to a group during 
all experiments. Animals from set 2 received either 
vehicle (DMSO 100%), LPI (10 nM) or CID16020046 (10 
nM). Each group were infused 5 min before the begin‑
ning of each training session (S1–S4).
Retention test
The day after the last training session, rats were 
evaluated in a retention test (a 4‑min trial per rat, just 
once). In this session (S5), rats were placed in the BM 
following the same procedure as in the training ses‑
sions, but no escape box was placed under any of the 
holes. The total time spent in the target zone (see 
above) was estimated (Fig. 2). It is noteworthy to men‑
tion that no treatment was infused before or during 
the retention test.
Drugs
In addition to anaesthetics (ketamine, xylazine, 
acepromazine), the compounds used in this study were 
Lysophosphatidylinositol (LPI, Sigma–Aldrich) and 
CID16020046 (Sigma‑Aldrich). LPI and CID16020046 
were dissolved in DMSO 100%. The dose used for LPI 
was selected based on its affinity for GPR55 (Table I) 
and pilot experiments. Whereas the dose used for 
CID16020046 was considered high enough to block 
GPR55 receptors (Marichal‑Cancino et al. 2016). The 
final volume for all injections was 0.5 µl per side. 
Statistical analyses
Results were analyzed as follows: latency to enter 
the escape tunnel (learning curve), errors, progres‑
sion in the strategies to solve the BM from session 1 
to session 4 and seconds per minute spent in the tar‑
get zone during the retention test were analyzed by 
means of a two‑way mixed ANOVA test (treatment x 
session; and treatment x seconds in target zone). In 
addition, strategies to solve the BM during the 16 tri‑
als and total time in the target zone during the reten‑
tion test in different groups were analyzed by means 
of a one‑way ANOVA test. Differences between treat‑
ments for each session were evaluated by Bonferroni 
post‑hoc test. Statistical significance was accepted at 
P<0.05. 
RESULTS
Latency (learning curve) and errors
Fig. 3A shows the latency to find the escape tun‑
nel in each session and Fig. 3B shows errors (visits 
to holes without the escape tunnel) in intact rats or 
those infused with vehicle (DMSO 100%), LPI (GPR55 
agonist) or CID16020046 (GPR55 antagonist) before 
each training session. No main differences among 
treatments (latency to escape) or interactions (treat‑
ments vs. sessions; learning curve) were detected 
(P>0.05). None of the treatments interfered with 
the latency to escape during sessions. However, dif‑
ferences between sessions (regardless of treatment) 
[F(3,84)=37.38, P<0.05] were detected. Session 1 was 
significantly different from session 4 (P<0.05; Fig. 3A). 
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Therefore, rats under all treatments displayed a nor‑
mal learning curve.
On the other hand, main differences in the 
quantity of errors for treatments [F(3,28)=3.319, 
P<0.05], sessions [F(3,84)=6.563, P<0.05] and inter‑
actions[F(9,84)=3.289, P<0.05] were detected. Rats 
infused with LPI committed more errors (particu‑
larly in the training session 2) than others (Fig. 3B). 
CID16020046, but not LPI exhibited a quantity of er‑
rors like intact or vehicle groups throughout sessions 
(i.e., S1 vs. S4; P<0.05; Fig. 3B).
Strategies used to solve the Barnes‑maze
Fig. 4 shows the use of different navigation strat‑
egies during the training phase (S1–S4, 16 trials in 
total) to solve the BM in intact rats, or when groups 
receiving vehicle (DMSO 100%), LPI or CID16020046 in‑
fusions, respectively. Main differences among groups 
were detected for serial strategy [F(3,28)=7.197, P<0.05] 
and random strategy [F(3,28)=14.280, P<0.05], but not 
for spatial strategy [F(3,28)=0.475, P>0.05]. Animals 
infused with LPI showed a high increase in the use of 
serial strategy compared with intact rats, vehicle and 
CID16020046 (P<0.05; Fig. 4A). No differences were de‑
tected in the use of spatial strategy (Fig. 4B). Animals 
treated with LPI showed a decrease in the use of ran‑
dom navigation compared with vehicle or CID16020046 
(Fig. 4C), while CID16020046 induced an increased in 
the use of the random navigation when compared with 
intact rats (P<0.05). 
Fig. 5 shows the progression in the strategy used by 
rats between first (assays 1–4) and last training days 
(assays 13–16) in intact rats or treatment groups. Main 
differences for treatments [F(3,56)=6.773, P<0.05] 
and differences among sessions [F(1,56)=5.120, 
P<0.05], but not interaction (treatments vs. ses‑
sions) [F(3,56)=2.613, P>0.05] were detected in the 
serial strategy. Rats infused with LPI highly increased 
the use of serial strategy from session 1 to session 4 
(P<0.05). Intact rats, vehicle or CID16020046 induced 
no change in this strategy throughout the sessions 
(Fig. 5A). Regarding the spatial strategy, differences 
only among sessions were detected [F(1,56)=11.570, 
P<0.05]. Intact rats and those infused with vehicle in‑
creased the use of spatial strategy from session 1 to 
session 4 (P<0.05); whereas rats infused with LPI or 
CID16020046 did not increase the use of this strategy 
throughout the sessions (Fig. 5B). For random strategy, 
main differences for treatments [F(3,56)=7.925, P<0.05], 
differences among sessions [F(1,56)=4.226, P<0.05], but 
not interactions [F(3,56)=2.201, P>0.05] were detected. 
Intact rats and those infused with vehicle decreased 
the use of random strategy from S1 to S4 (P<0.05). LPI 
dramatically reduced the use of random strategy from 
session 1 to session 4 compared with intact rats, vehi‑
cle or CID16020046. Finally, CID16020046 group showed 
Fig. 3. Effects of lysophosphatidylinositol and CID16020046 on latency and errors during training in Barnes‑maze. Apart from intact rats, other groups (n=8 
each group) received infusions into the dorsal hippocampus of vehicle (DMSO 100%), lysophosphatidylinositol (10 nM) or CID16020046 (10 nM) before 
training sessions. (A) latency and learning curve. (B) errors. Σ, P<0.05 vs. any other group.
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no reduction in random activity during sessions and 
induced more random activity compared with intact 
rats (Fig. 5C). 
Retention test
Fig. 6 illustrates time spent in the target zone during 
the retention test (S5; a single 4‑min trial). Main differ‑
ences among treatments [F (3, 29)=7.536, P<0.05] were 
detected. LPI and CID16020046‑infused rats spent less 
total time than intact rats in the target zone. Moreover, 
CID1602046‑infused rats spent less time than vehicle 
group (P<0.05).
DISCUSSION
General 
Hippocampal activity (among several other func‑
tions) allows us to locate specific places or objects in 
Fig. 4. Effect of lysophosphatidylinositol and CID16020046 on the navigation strategy used during the training phase. Data represent the mean of the 
strategy used during four training sessions (16 trials). Apart from intact rats, other groups (n=8 each group) received infusions into the dorsal hippocampus 
of vehicle (DMSO 100%), lysophosphatidylinositol (10 nM) or CID16020046 (10 nM) before each training session. (A) serial strategy, (B) spatial strategy and 
(C) random strategy. Σ, P<0.05 vs. any other group; *, P<0.05 vs. vehicle group; δ, P<0.05 vs. CID16020046 and β, P<0.05 vs. intact rats.
Fig. 5. Progression in the use of navigation strategies. Rats (n=8 each group) received infusions into the dorsal hippocampus of vehicle (DMSO 100%), 
lysophosphatidylinositol (10 nM) or CID16020046 (10 nM) before 4 training  sessions. Main effects of treatments,  sessions (S1 vs. S4) and interaction 
(treatments vs. sessions) were analyzed for navigation strategies among groups. (A) Serial strategy; (B) spatial strategy; (C) random strategy. *, P<0.05 
main differences vs. vehicle group; ρ, P<0.05 main differences vs. CID16020046 group. σ, P<0.05 S1 vs. S4; Σ, P<0.05 vs. any other group; *, P<0.05 vs. vehicle 
group and β, P<0.05 vs. intact rats.
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space and it is involved in choosing the trajectory to 
be used in a goal‑directed behaviour (Evensmoen et al. 
2013, Ito et al. 2015, Manns and Eichenbaum 2009). In the 
present study, we found that hippocampal injections of 
LPI (GPR55 agonist) increased the use of the serial navi‑
gation strategy. 
Fouquet et al. (2013) reported that lesions in the dorsal 
hippocampus increased the use of serial navigation. Nev‑
ertheless, lesions in the dorsal striatum did not decrease 
the use of the serial strategy and abolished the use of a di‑
rect (spatial) strategy, suggesting potential communica‑
tion between hippocampus and striatum in establishing 
a spatial navigation strategy. Under certain experimental 
conditions, spatial navigation involves cooperative activ‑
ity between different brain structures such as the dorsal 
hippocampus and the dorsal striatum (Chersi and Burgess 
2015, Doeller et al. 2008, Fouquet et al. 2013). Interestingly, 
stimulation of GPR55 in the dorsal striatum increased the 
learning of procedural memories (Marichal‑Cancino et al. 
2016). In addition, mutant mice that lack GPR55 showed 
a high impairment in motor coordination (Wu et al. 2013). 
Thus, this receptor may be important in coordinating se‑
quential motor actions at different levels (Marichal‑Can‑
cino et al. 2017). 
Our results suggest a potential role for LPI, acting on 
hippocampal neurons (probably via GPR55) in the neu‑
ral‑circuitry involved in coordinating spatial navigation 
strategies. Supporting the above, blockade of GPR55 be‑
fore training increased random navigation activity. The 
above indicates that integrity of GPR55 pathway may be 
required to establish a specific navigation strategy. Final‑
ly, blockade of GPR55 during the training phase decreased 
time spent in the escape tunnel placement. This result 
may point out a role of GPR55 in the formation of spatial 
memory. However, more experiments need to be devel‑
oped to clarify this possibility.
Latency, learning curve and errors
In these experiments, we used an aversive version of 
the Barnes maze (Harloe et al. 2008). The rodents were 
motivated to find the escape tunnel to avoid exposure 
to light and noise (90 dB) as previously described (Har‑
loe et al. 2008, Rueda‑Orozco et al. 2008). In this con‑
text, learning in solving the task was inferred from the 
reduction in latency to find the escape tunnel, thus, 
eluding these aversive conditions. Interestingly, GPR55 
pharmacological activation or blockade before training 
induced no changes in the latency to escape. There‑
fore, the learning curve across training‑sessions is not 
different from the control. Thus, hippocampal GPR55 
could not be involved in the regulation of the motiva‑
tion to escape from this aversive condition. This result 
agrees with Kramar et al. (2017), which concluded no 
participation of GPR55 in context fear conditioning test 
under their experimental conditions. 
On the other hand, animals receiving LPI commit‑
ted a higher number of errors across the training ses‑
sions. As LPI increased the use of the serial strategy 
(which requires subsequent visits to non‑target holes), 
this higher number of errors may reflect the navigation 
strategy used (see below). 
Possible mechanisms involved in the effects of 
LPI on the navigation strategies to solve the BM
We have previously reported (Rueda‑Orozco et al. 
2008) that anandamide infusions in CA1 significant‑
ly modified the use of the spatial or serial navigation 
strategy. The actions of anandamide were resistant to 
blockade with AM251 (CB1 inverse agonist/antagonist) 
suggesting the potential participation of other can‑
nabinoid target receptors. As GPR55 is expressed in 
the hippocampus (Ryberg et al. 2007) and other brain 
structures where the actions have been only partially 
identified (Marichal‑Cancino et al. 2017), it was logical 
to assume that this receptor may be involved. 
Our data show that CA1‑hippocampus infusions of 
a GPR55 endogenous agonist (LPI) promoted the use of 
the serial strategy, while preventing learning of the spa‑
Fig.  6. Effect of lysophosphatidylinositol and CID16020046 on the 
retention test. Apart from intact rats, other groups (n=8 each group) 
received infusions of vehicle (DMSO 100%), lysophosphatidylinositol (10 
nM) or CID16020046 (10 nM) during the training phase; no treatment 
was infused on the retention test day. Data represent total time spent in 
target zone in the single 4‑minute trial. *, P<0.05 vs. vehicle group and β, 
P<0.05 vs. intact rats.
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tial strategy. The above suggests that LPI may be altering 
hippocampal activity related with goal‑directed naviga‑
tion behaviours. In in vitro models, hippocampal GPR55 
activation increases the probability of glutamate and do‑
pamine release (Kramar et al. 2017, Sylantyev et al. 2013). 
If GPR55 enhances hippocampal activity in vivo also, there 
are at least four speculative possibilities to explain our 
results: (i) after GPR55 stimulation and the subsequent 
glutamate/dopamine induction, other neurotransmitters 
may be recruited to decrease goal‑directed behaviours 
(e.g. endocannabinoids; see below); (ii) hippocampal 
GPR55 expressing‑neurons may be involved in serial navi‑
gation (or in actions that alter spatial navigation); (iii) LPI 
may be activating other receptors (different or aside from 
GPR55); and (iv) hippocampal GPR55 may be involved in 
the exploratory behaviour. 
Supporting the first speculation, GPR55 activation 
seems to increase the release of glutamate (Sylantyev 
et al. 2013) that may open NMDA receptors facilitating 
Ca2+ currents into the postsynaptic neuron. In addition, 
GPR55 may raise intracellular Ca+2 (Henstridge et al. 
2010). In other studies, elevation in levels of intracellu‑
lar Ca+2 increased the synthesis of anandamide and the 
activation of phospholipase C; which in turn, induced 
synthesis of 2‑arachydonoyl glycerol (2‑AG) (Jung et 
al. 2007, Hashimotodani et al. 2008). These endocanna‑
binoids might interact with hippocampal cannabinoid 
receptors. On the other hand, increase in dopaminergic 
activity induced by hippocampal injections of palmitoy‑
lethanolamide (non‑selective GPR55 endogenous ago‑
nist) were prevent in presence of CID160120046 (GPR55 
antagonist) or MK801 (NMDA receptor antagonist) sug‑
gesting glutamate participation in the mention effects 
(Kramar et al. 2017). 
To support the second possibility, several authors 
have reported non‑spatial behaviours involving hippo‑
campal neurons (Cohen et al. 2013, Hampson et al. 1999, 
Wood et al. 1999, Yi et al. 2016). Some evidence suggests 
a cooperative action of dorsal hippocampus with striatal 
areas to allow spatial navigation in the Morris‑maze (Mi‑
yoshi et al. 2012) signifying simultaneous activity in both 
structures as reported by others (Regier et al. 2015). Thus, 
hippocampal GPR55 expressing‑neurons may be involved 
in the expression of the serial navigation strategy via in‑
teraction with striatal neurons. In addition, Rahimi et al. 
(2015) reported that central GPR55 stimulation induced 
an anxiolytic effect that could be influencing the naviga‑
tion behaviour in rats. At this respect, Morena et al. (2015) 
established a relationship between stress levels and can‑
nabinoid activity modulating spatial memory. 
On the other hand, LPI seems to induce effects via 
other non‑GPR55. Soga et al. (2005) reported that LPI 
(in vitro) induced insulin secretion by GPR119. Monet 
et al. (2009) reported induction of cell migration after 
LPI by TRPV2. mRNA for GPR119 (Bonini et al. 2002) 
and TRPV2 (Pan et al. 2011) have been reported in hip‑
pocampal tissue, but their functions (if any) remain 
obscure. Lastly, hippocampal GPR55 could be involved 
in controlling exploratory behaviour which may be re‑
sponsible for changes seen during the tests (Good and 
Honey 1997, Hernández‑Tristán et al. 2000). Neverthe‑
less, exploratory behaviour during retention test was 
decreased in rats infused with LPI and no differences 
in latency to escape from Barnes‑maze were detected. 
Finally, blockade of GPR55 with a selective antago‑
nist (CID16020046; Kargl et al. 2013) increased the use 
of random navigation (Fig. 4C and Fig. 5C) suggesting 
that GPR55 signalling pathway integrity may be a re‑
quirement to establish a specific navigation strategy. 
The retention test: spatial memory
GPR55 blockade during acquisition in the BM de‑
creased the time spent in the target zone during the re‑
tention test. Since animals received no drugs during the 
retention test day, this test involved effects on learning 
and/or memory formation during the training phase. 
Nevertheless, one may argue that the state during reten‑
tion test session was different from that during training 
phase (since rats received treatment only during train‑
ing phase); thus, other effects (not tested in this study) 
could have interfered with behavior of rats at retention 
test session. At any case, these preliminary results should 
motivate the advent or further experimental protocols di‑
rected to analyze the specific functionality of hippocam‑
pal GPR55 in spatial learning and memory. 
CONCLUSIONS
Taken together, our findings suggest that LPI inter‑
acts with CA1 hippocampal cells that may be involved in 
the expression of serial navigation. On the other hand, 
GPR55 signaling integrity seems to be necessary to in‑
tegrate a specific navigation strategy. Finally, our data 
suggest the existence of a potential participation of hip‑
pocampal GPR55 during formation/acquisition of spa‑
tial memory (specifically, object placement memory).
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